🇺🇸 FDA
Patent

US 11479769

Technique for treating cancer using structurally-reinforced S-TuD

granted A61KA61K31/7105A61K31/713

Quick answer

US patent 11479769 (Technique for treating cancer using structurally-reinforced S-TuD) held by GeneDesign, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GeneDesign, Inc.
Grant date
Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/7105, A61K31/713, A61K9/127, A61K9/14